Augmentation-Based Deep Learning for Identification of Circulating Tumor Cells
Circulating tumor cells (CTCs) are crucial biomarkers in liquid biopsy, offering a noninvasive tool for cancer patient management. However, their identification remains particularly challenging due to their limited number and heterogeneity. Labeling samples for contrast limits the generalization of fluorescence-based methods across different hospital datasets. Analyzing single-cell images enables detailed assessment of cell morphology, subcellular structures, and phenotypic variations, often hidden in clustered images. Developing a method based on bright-field single-cell analysis could overcome these limitations. CTCs can be isolated using an unbiased workflow combining Parsortix technology, which selects cells based on size and deformability, with DEPArray technology, enabling precise visualization and selection of single cells. Traditionally, DEPArray-acquired digital images are manually analyzed, making the process time-consuming and prone to variability. In this study, we present a Deep Learning-based classification pipeline designed to distinguish CTCs from leukocytes in blood samples, aimed to enhance diagnostic accuracy and optimize clinical workflows. Our approach employs images from the bright-field channel acquired through DEPArray technology leveraging a ResNet-based CNN. To improve model generalization, we applied three types of data augmentation techniques and incorporated fluorescence (DAPI) channel images into the training phase, allowing the network to learn additional CTC-specific features. Notably, only bright-field images have been used for testing, ensuring the model's ability to identify CTCs without relying on fluorescence markers. The proposed model achieved an F1-score of 0.798, demonstrating its capability to distinguish CTCs from leukocytes. These findings highlight the potential of DL in refining CTC analysis and advancing liquid biopsy applications.
Code (0)
등록된 구현이 없습니다.
Tasks
Data AugmentationDiagnosticSimilar Papers 제목 키워드 기반
Automated Multi-Process CTC Detection using Deep Learning
Circulating Tumor Cells (CTCs) bear great promise as biomarkers in tumor prognosis. However, the process of identification and later enumeration of CTCs require manual labor, which is error-prone and time-consuming. The …
Cell DetectionDeep Learningobject-detectionObject Detection+1Characterization of a novel automated microfiltration device for the efficient isolation and analysis of circulating tumor cells from clinical blood samples
The detection and analysis of circulating tumor cells (CTCs) may enable a broad range of cancer-related applications, including the identification of acquired drug resistance during treatments. However, the non-scalable …
Deciphering circulating tumor cells binding in a microfluidic system thanks to a parameterized mathematical model
The spread of metastases is a crucial process in which some questions remain unanswered. In this work, we focus on tumor cells circulating in the bloodstream, the so-called Circulating Tumor Cells (CTCs). Our aim is to c…
Magnetic Iron Nanocubes Effectively Capture Epithelial and Mesenchymal Cancer Cells
Current methods for capturing circulating tumor cells (CTCs) are based on the overexpression of cytokeratin (CK) or epithelial cell-adhesion molecule (EpCAM) on cancer cells. However, during the process of metastasis, tu…
SpecificityAutomatic Classification of Circulating Blood Cell Clusters based on Multi-channel Flow Cytometry Imaging
Circulating blood cell clusters (CCCs) containing red blood cells (RBCs), white blood cells(WBCs), and platelets are significant biomarkers linked to conditions like thrombosis, infection, and inflammation. Flow cytometr…